Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population

AIDS

Volumn 18, Issue 4, 2004, Pages 615-619

  Sagar, Manish ^a   Lavreys, Ludo ^a,b   Baeten, Jared M ^a   Richardson, Barbra A ^a   Mandaliya, Kishorchandra ^c   Ndinya Achola, Jeckoniah O ^b   Kreiss, Joan K ^a   Overbaugh, Julie ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

DMPA; Genetic diversity; Heterosexual transmission; HIV 1; Hormonal contraceptives; Oral contraceptives; Sexually transmitted diseases

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; VIRUS RNA;

ADULT; ARTICLE; CHLAMYDIASIS; CONDOM; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENITAL TRACT INFECTION; GENITAL ULCER; GENOTYPE; GONORRHEA; HETEROSEXUALITY; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTITUTION; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; UTERINE CERVICITIS; VAGINA DISCHARGE; VAGINITIS; VIRUS TRANSMISSION; VULVITIS;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; EPIDEMIOLOGIC METHODS; FEMALE; GENITAL DISEASES, FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PROSTITUTION; SEXUALLY TRANSMITTED DISEASES; VARIATION (GENETICS); VIRAL LOAD;

EID: 1642369382     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403050-00005     Document Type: Article

References (21)

1. Poss M, Martin HL, Kreiss JK, Granville L, Chohan B, Nyange P, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 1995, 69: 8118-8122.
2. Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, Goudsmit J. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997, 227:63-76.
3. Long EM, Martin HL, Jr., Kreiss JK, Rainwater SM, Lavreys L, Jackson DJ, et al. Gender differences in HIV-1 diversity at time of infection. Nature Med 2000, 6:71-75.
4. Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Chohan BH, et al. Infection with multiple HIV-1 variants is associated with faster disease progression. J Virol 2003, 17: 12921-12926.
5. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 75:3-17.
6. Plummer FA. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retroviruses 1998, 14(Suppl 1): S5-S10.
7. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998, 351:SIII5-SIII7.
8. Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and the risk of heterosexual transmission of HIV-1. J Infect Dis 1998, 178:1053-1059.
9. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999, 21:51-58.
10. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:500-507.
11. Bulterys M, Chao A, Habimana P, Dushimimana A, Nawrocki P, Saah A. Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS 1994, 8:1585-1591.
12. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
13. Saracco A, Musicco M, Nicolosi A, Angarano G, Arici C, Gavazzeni G, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr 1993, 6:497-502.
14. Sinei SK, Fortney JA, Kigondu CS, Feldblum PJ, Kuyoh M, Allen MY, et al. Contraceptive use and HIV infection in Kenyan family planning clinic attenders. Int J STD AIDS 1996, 7:65-70.
15. Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS 1998, 12:545-553.
16. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 2003, 1:69-86.
17. Lavreys L, Baeten JM, Kreiss JK, Richardson BA, Chohan BH, Hassan W, et al. Injectable contraceptives use and genital ulcer disease during early Human Immunodeficiency Virus Type 1 (HIV-1) infection increase plasma virus load among women. J Infect Dis 2004, 189:303-311.
18. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996, 2:1084-1089.
19. Hunt JS, Miller L, Platt JS. Hormonal regulation of uterine macrophages. Dev Immunol 1998, 6:105-110.
20. Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol 2002, 124:106-114.
21. Prakash M, Kapembwa MS, Gotch F, Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002, 54:117-131.